Neuraxis, INC (NRXS) Stock Forecast

NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth

2h ago, source: None

NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.

NeurAxis, Inc. Reports Robust Q2 2025 Growth

5d ago, source: None

NeurAxis, Inc. ( (NRXS) ) has released its Q2 earnings. Here is a breakdown of the information NeurAxis, Inc. presented to its investors.Elevate Your Investing Strategy: Take advantage of TipRanks ...

NeurAxis, Inc. Reports 43% Revenue Growth in Q4 2024 and ... - Nasdaq

5mon ago, source: Nasdaq

NeurAxis, Inc. reported its fourth quarter and fiscal year 2024 results, highlighting a significant 43% increase in revenue to $761,000 compared to the same period last year.

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor ...

7mon ago, source: Morningstar

CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies ...

NeurAxis, Inc. Reports 39% Revenue Growth in Q1 2025 Amid ... - Nasdaq

3mon ago, source: Nasdaq

NeurAxis, Inc. reported a strong first quarter for 2025, with revenues increasing 39% year-over-year to $896,000, marking an 18% rise from the previous quarter.

NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter ...

7mon ago, source: Seeking Alpha

Revenues in 4Q24 increased approximately 50% versus 4Q23 Cash balance as of 12/31/24 was approximately $3.7 million CARMEL, Ind., Jan. 08, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NRXS), a medical ...

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business ...

5mon ago, source: Business Insider

CARMEL, Ind., March 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies ...

NeurAxis to Host Second Quarter 2024 Results and ... - Markets Insider

1y ago, source: Business Insider

About NeurAxis, Inc. NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults.

NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and ...

8mon ago, source: Seeking Alpha

NeurAxis Inc. (NRXS) will begin the process of commercially marketing RED and expects initial revenues in 1Q25 as there is a Category I CPT code assigned to the procedure and the procedure is ...

NeurAxis Announces $5.0 Million Registered Direct Offering

2mon ago, source: The National Law Review

Contacts: CompanyNeurAxis, Inc. info@neuraxis.com Investor Relations Lytham Partners Ben Shamsian 646-829-9701 shamsian@lythampartners.com Print ...

Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)

3mon ago, source: The Wall Street Transcript

Brian Carrico is the President and Chief Executive Officer of NeurAxis, Inc., a growth stage med-tech company addressing chronic and debilitating conditions in children. Mr. Carrico also serves as ...

NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter ...

7mon ago, source: Morningstar

NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults.

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Axogen, Inc.	AXGN	Predict	683.28	-41.70	6.09
BIOLIFE SOLUTIONS INC	BLFS	Predict	990.70	-14.65	2.81
BioSig Technologies, Inc.	BSGM	Predict	126.37	-1.82	48.51
Ceribell, Inc.	CBLL	Predict	450.54	None	2.62
CONMED Corp	CNMD	Predict	1656.44	15.03	1.65
CUTERA INC	CUTR	Predict	9.08	-0.06	-0.04
CapsoVision, Inc	CV	Predict	-0.32	None	None
electroCore, Inc.	ECOR	Predict	39.09	-7.26	35.12
EDAP TMS SA	EDAP	Predict	55.15	None	1.35
Electromed, Inc.	ELMD	Predict	170.00	23.74	3.87
FONAR CORP	FONR	Predict	95.72	9.22	0.61
GUIDED THERAPEUTICS INC	GTHP	Predict	21.72	None	None
HELIUS MEDICAL TECHNOLOGIES, INC.	HSDT	Predict	66.46	-0.04	51.92
Hyperfine, Inc.	HYPR	Predict	147.70	-1.83	0.89
InMode Ltd.	INMD	Predict	1156.56	None	1.64
IRIDEX CORP	IRIX	Predict	19.00	-2.75	3.14
IR-Med, Inc.	IRME	Predict	1.37	None	None
Integer Holdings Corp	ITGR	Predict	3826.29	46.29	2.25
LivaNova PLC	LIVN	Predict	2932.59	-662.01	2.61
MASIMO CORP	MASI	Predict	8447.46	128.12	8.10
Medtronic plc	MDT	Predict	120566.14	25.86	2.51
Movano Inc.	MOVE	Predict	5.42	-8.57	0.74
ENDRA Life Sciences Inc.	NDRA	Predict	1.92	-0.78	1.10
Neuraxis, INC	NRXS	Predict	23.76	-0.86	5.59
Nuwellis, Inc.	NUWE	Predict	64.73	-0.06	18.09
Nexalin Technology, Inc.	NXL	Predict	13.66	-4.68	2.29
Nexalin Technology, Inc.	NXLIW	Predict	4.77	None	0.96
Outset Medical, Inc.	OM	Predict	236.11	-0.41	1.52
PRECISION OPTICS CORPORATION, INC.	POCI	Predict	36.49	-11.54	2.77
QT IMAGING HOLDINGS, INC.	QTI	Predict	7.20	-0.42	-0.75
SOLENO THERAPEUTICS INC	SLNO	Predict	4416.52	-18.46	19.02
Semler Scientific, Inc.	SMLR	Predict	463.22	12.50	1.21
STAR EQUITY HOLDINGS, INC.	STRR	Predict	6.87	-1.60	0.11
STAR EQUITY HOLDINGS, INC.	STRRP	Predict	30.45	-5.50	0.49
Stereotaxis, Inc.	STXS	Predict	1112.32	-8.43	763.96
Tivic Health Systems, Inc.	TIVC	Predict	3.66	-0.03	0.99
TransMedics Group, Inc.	TMDX	Predict	5138.86	71.71	16.16
Vivani Medical, Inc.	VANI	Predict	91.83	-2.67	7.90
VASO Corp	VASO	Predict	22.85	20.10	0.86
ZYNEX INC	ZYXI	Predict	47.01	41.41	37.28